Pancreatic β-cells express hepcidin, an iron-uptake regulatory peptide

被引:94
作者
Kulaksiz, Hasan [1 ]
Fein, Evelyn [2 ]
Redecker, Peter [3 ]
Stremmel, Wolfgang [2 ]
Adler, Guido [1 ]
Cetin, Yalcin [4 ]
机构
[1] Univ Hosp Ulm, Dept Internal Med, Div Gastroenterol, D-89081 Ulm, Germany
[2] Univ Heidelberg Hosp, Dept Internal Med, Div Gastroenterol, D-69120 Heidelberg, Germany
[3] Ctr Anat, Hannover Med Sch, Dept Cell Biol, D-30625 Heidelberg, Germany
[4] Univ Marburg, Inst Anat & Cell Biol, Dept Mol Cell Biol, D-35033 Marburg, Germany
关键词
D O I
10.1677/JOE-07-0528
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Body iron is involved in various vital functions. Its uptake in the intestine is regulated by hepcidin, I bioactive peptide originally identified in plasma and urine and subsequently in the liver. In the present study, we provide evidence at the transcriptional and translational levels that hepcidin is also expressed in the pancreas of rat and man. Immunohistochemical studies localized the peptide exclusively to P-cells of the islets of Langerhans. Immunoelectron microscopical analyses revealed that hepcidin is confined to the insulin-storing beta-cell secretory granules. As demonstrated in insulinoma-derived RINm5F cells, the expression of hepcidin in P-cells is regulated by iron. Based on the present findings we conclude that pancreatic islets are all additional source of the peptide hepcidin. The localization of this peptide to beta-cells suggests that pancreatic beta-cells may be involved in iron metabolism in addition to their genuine e function in blood glucose regulation. In view of the various linked iron/glucose disorders in the pancreas, the present findings may provide an insight into the phenomenology of intriguing mutual relationships between iron and glucose metabolisms.
引用
收藏
页码:241 / 249
页数:9
相关论文
共 37 条
[1]   Increased insulin secretory capacity but decreased insulin sensitivity after correction of iron overload by phlebotomy in hereditary haemochromatosis [J].
Abraham, D. ;
Rogers, J. ;
Gault, P. ;
Kushner, J. P. ;
McClain, D. A. .
DIABETOLOGIA, 2006, 49 (11) :2546-2551
[2]   Medical progress: Disorders of iron metabolism [J].
Andrews, NC .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (26) :1986-1995
[3]   Hemochromatosis: Genetics and pathophysiology [J].
Beutler, E .
ANNUAL REVIEW OF MEDICINE, 2006, 57 :331-347
[4]   RESPONSE TO REPEATED PHLEBOTOMIES IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS [J].
BOFILL, C ;
JOVEN, J ;
BAGES, J ;
VILELLA, E ;
SANS, T ;
CAVALLE, P ;
MIRALLES, R ;
LLOBET, J ;
CAMPS, J .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1994, 43 (05) :614-620
[5]   Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis [J].
Bridle, KR ;
Frazer, DM ;
Wilkins, SJ ;
Dixon, JL ;
Purdie, DM ;
Crawford, DHG ;
Subramaniam, VN ;
Powell, LW ;
Anderson, GJ ;
Ramm, GA .
LANCET, 2003, 361 (9358) :669-673
[6]   CHROMOSTATIN, A CHROMOGRANIN-A-DERIVED BIOACTIVE PEPTIDE, IS PRESENT IN HUMAN PANCREATIC INSULIN (BETA) CELLS [J].
CETIN, Y ;
AUNIS, D ;
BADER, MF ;
GALINDO, E ;
JORNS, A ;
BARGSTEN, G ;
GRUBE, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (06) :2360-2364
[7]   Effect of phlebotomy on plasma glucose and insulin concentrations [J].
Facchini, FS .
DIABETES CARE, 1998, 21 (12) :2190-2190
[8]   Regulation of hepcidin in HepG2 and RINm5F cells [J].
Fein, Evelyn ;
Merle, Uta ;
Ehehalt, Robert ;
Herrmann, Thomas ;
Kulaksiz, Hasan .
PEPTIDES, 2007, 28 (05) :951-957
[9]   Blood letting in high-ferritin type 2 diabetes -: Effects on insulin sensitivity and β-cell function [J].
Fernández-Real, JM ;
Peñarroja, G ;
Castro, A ;
García-Bragado, F ;
Hernández-Aguado, D ;
Ricart, W .
DIABETES, 2002, 51 (04) :1000-1004
[10]   Cross-talk between iron metabolism and diabetes [J].
Fernández-Real, JM ;
López-Bermejo, A ;
Ricart, W .
DIABETES, 2002, 51 (08) :2348-2354